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Abstract
Background: Of the > 2000 serovars of Salmonella enterica subspecies I, most cause self-limiting
gastrointestinal disease in a wide range of mammalian hosts. However, S. enterica serovars Typhi
and Paratyphi A are restricted to the human host and cause the similar systemic diseases typhoid
and paratyphoid fever. Genome sequence similarity between Paratyphi A and Typhi has been
attributed to convergent evolution via relatively recent recombination of a quarter of their
genomes. The accumulation of pseudogenes is a key feature of these and other host-adapted
pathogens, and overlapping pseudogene complements are evident in Paratyphi A and Typhi.
Results: We report the 4.5 Mbp genome of a clinical isolate of Paratyphi A, strain AKU_12601,
completely sequenced using capillary techniques and subsequently checked using Illumina/Solexa
resequencing. Comparison with the published genome of Paratyphi A ATCC9150 revealed the two are
collinear and highly similar, with 188 single nucleotide polymorphisms and 39 insertions/deletions. A
comparative analysis of pseudogene complements of these and two finished Typhi genomes (CT18,
Ty2) identified several pseudogenes that had been overlooked in prior genome annotations of one or
both serovars, and identified 66 pseudogenes shared between serovars. By determining whether each
shared and serovar-specific pseudogene had been recombined between Paratyphi A and Typhi, we
found evidence that most pseudogenes have accumulated after the recombination between serovars.
We also divided pseudogenes into relative-time groups: ancestral pseudogenes inherited from a
common ancestor, pseudogenes recombined between serovars which likely arose between initial
divergence and later recombination, serovar-specific pseudogenes arising after recombination but prior
to the last evolutionary bottlenecks in each population, and more recent strain-specific pseudogenes.
Conclusion: Recombination and pseudogene-formation have been important mechanisms of
genetic convergence between Paratyphi A and Typhi, with most pseudogenes arising independently
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after extensive recombination between the serovars. The recombination events, along with
divergence of and within each serovar, provide a relative time scale for pseudogene-forming
mutations, affording rare insights into the progression of functional gene loss associated with host
adaptation in Salmonella.
Background
Salmonella enterica serovars Typhi and Paratyphi A
(Typhi, Paratyphi A) are human-restricted bacterial
pathogens that cause related systemic diseases, known
as typhoid, paratyphoid or enteric fever [1]. Together,
these pathogens infect more than 25 million people
annually worldwide, resulting in > 200,000 deaths [2].
Historically, Paratyphi A was responsible for less than
20% of these infections [2], however Paratyphi A
infection rates have been rising, particularly in South
East Asia where this serovar is now responsible for 30–
50% of enteric fever cases [3-6]. This increase has been
associated with rises in antibiotic resistance among
paratyphoid infections [3, 7, 8]. It may also be associated
with vaccination against Typhi, which unfortunately
provides little cross-protection against Paratyphi A [9,
10]. Finished genomic sequence is currently available for
two Typhi isolates (recent clinical isolate CT18 and
laboratory strain Ty2) and one Paratyphi A isolate
(laboratory strain ATCC9150) [11-13].
Typhi and Paratyphi A are unusual among S. enterica, as
most serovars infect a broad range of host species and
cause self-limiting gastroenteritis, while Typhi and
Paratyphi A infect only humans and cause systemic
disease [14]. The basis for their unusual shared
phenotype is unclear. Whole-genome sequence compar-
isons suggest that the Paratyphi A and Typhi chromo-
somes are much more closely related at the DNA level
than other S. enterica serovars. Furthermore the genomes
of both organisms harbour a large number of pseudo-
genes (> 4% of coding sequences in each genome)
[11-13] compared to host-generalist relatives such as
S. enterica serovar Typhimurium (0.9%) or E. coli K12
(0.7%).
A recent study showed that the apparent similarity
between Paratyphi A and Typhi genome sequences is
due to low nucleotide divergence (mean 0.18%) across a
quarter of the genome, while the rest of the genome
sequences are as divergent as any other pair of S. enterica
serovars (mean 1.2%) [15]. The study used model-based
approaches to demonstrate that this is due to relatively
recent convergence via recombination between 23% of
the Paratyphi A and Typhi genomes, whose initial
divergence occurred around the same time as that of
other S. enterica serovars. It is possible that this extensive
recombination was responsible for the convergence of
Paratyphi A and Typhi on a human-restricted lifestyle,
however it is also plausible that the serovars followed
independent paths to host-restriction and the opportu-
nity for recombination arose after they became isolated
together in this shared niche. The direction of recombi-
nation cannot be determined, and may have been uni- or
bi-directional.
Pseudogenes are coding sequences (CDS) that are puta-
tively inactivated by mutations including nonsense
substitutions, frameshifts, or truncation by deletion or
rearrangement. Loss of gene function through pseudogene
formation and gene deletion appears to be a hallmark of
host-restricted pathogenic bacteria compared to their host-
generalist relatives [11, 13, 16-19]. This is likely due to a
combination of adaptation (whereby loss of gene function
is selected for in the new host) and genetic drift associated
with population bottlenecks during or following adapta-
tion to the new niche. It has been reported that Paratyphi
A and Typhi share some of their pseudogenes [13],
resulting in convergent loss of gene functions which may
be associated with adaptation to their shared niche. The
genomes of S. enterica encode two type III secretion systems
(TTSS), which mediate secretion of a range of effector
proteins into host cells [20]. Many of these effectors are
encoded in Salmonella pathogenicity islands 1 and 2 (SPI-1
and SPI-2, reviewed in [20, 21]), including several that are
pseudogenes in Typhi and/or Paratyphi A. The inactivation
of these and other genes involved in interactions between
Salmonella and host is thought to play a key role in the host
adaptation of these serovars [11, 13].
Here we report the 4.5 Mbp genome sequence of a recent
clinical isolate of Paratyphi A, strain AKU_12601, allowing
the first comparative analysis between two Paratyphi A
isolates at the whole-genome sequence level. We also
present a novel comparative annotation of pseudogenes in
all four Paratyphi A and Typhi genomes. This is combined
with previously reported divergence data [15] in order to
tease apart the roles that recombination and pseudogene
formation have played in the genetic and phenotypic
convergence of Paratyphi A and Typhi.
Results and Discussion
Sequencing the Paratyphi A AKU_12601 genome
The whole genome sequence of Paratyphi A strain
AKU_12601 was assembled, finished and annotated as
BMC Genomics 2009, 10:36 http://www.biomedcentral.com/1471-2164/10/36
Page 2 of 12
(page number not for citation purposes)
described in the Methods section. The genome consists of a
4,581,797 bp circular chromosome, encoding 4,285 CDS,
and a 212,711 bp IncHI1 multidrug resistance plasmid
pAKU_1 [EMBL:AM412236] which has been described in
detail elsewhere [22]. The AKU_12601 genome was also
resequenced using the Illumina Genome Analyzer (Illu-
mina), to a depth of 20-fold coverage. Short reads (35 bp)
generated by resequencing were aligned to the finished
sequence, which identified five high quality single base
discrepancies between the assemblies (see Methods). One
was found to be an erroneous base call in the finished
sequence following checking of trace files and was
corrected prior to EMBL submission. The remaining four
bases (6-, 8-, 10-, and 20-fold read depth in Illumina data)
may be errors in the Illumina resequencing, or reflect
genuine mutations arising during culturing in the
laboratory.
Data accessions
The finished sequence and annotation of the AKU_12601
genome is available in EMBL under accession FM200053,
and the Illumina resequencing data is available under
accession ERA000012 ftp://ftp.era.ebi.ac.uk/.
Comparison of Paratyphi A strains
AKU_12601 and ATCC9150
Comparative analysis revealed the two Paratyphi A
genomes to be collinear, with no rearrangements and no
acquisitions of phage or other large mobile elements. In
contrast, Typhi Ty2 contains an inversion of half the
genome between two rRNA operons and large-scale phage
variation compared to Typhi CT18 [12]. Several insertion/
deletion events and substitutions were identified between
the Paratyphi A genomes.
Insertions and deletions
A total of 39 insertion/deletion events, including
13 differences in homopolymeric tracts, were identified
between AKU_12601 and ATCC9150 (Table 1). Two
IS10 elements were inserted in AKU_12601, within the
nmpC gene and a hypothetical pseudogene (SSPA4008a/
SPA4318). Six variable number tandem repeats (VNTRs)
were identified, including one less tandem copy each of
the tRNA-Gly and rrT RNA genes in AKU_12601.
The largest single locus difference between the two
genomes occurs within the O-antigen biosynthetic
cluster rfb, where a 2.7 kb sequence including the 3'
end of putative O-antigen transporter rfbX (SSPA0733)
and two putative glycosyltransferase genes (rfbV/
SSPA0734 and 5' end of rfbU/SSPA0735) is present in
three tandem copies in ATCC9150. A single copy of this
sequence is present in other S. enterica serovars [23],
therefore the AKU_12601 sequence is assumed to be the
ancestral form. The repeats in ATCC9150 generate two
copies of a chimeric coding sequence, combining the 5'
end of rfbU with the 3' end of rfbX (Figure 1). These
genes are involved in synthesis and transport of
O-antigen [23], but it is unclear whether the increased
copy number and chimeric sequences generated by these
repeats cause any functional differences in O-antigen
expression between ATCC9150 and AKU_12601.
An additional 122 bp sequence was present in AKU_12601
between the iap and ygbF genes, including two additional
copies of a 30 bp repeat sequence present in six copies in
Table 1: Insertion/deletion events between Paratyphi A
AKU_12601 and ATCC9150
Coding effect Gene Mutation
pseudo-forming aidB 217 bp del
pseudo-forming asnB 1 bp del (homopol)
pseudo-forming ccmH 95 bp del
pseudo-forming nmpC 1338 bp ins (IS10)
pseudo-forming pduF 1 bp del (homopol)
pseudo-forming pduG 171 del
pseudo-forming proQ 7 bp del
pseudo-forming rbsC 1 bp ins (homopol)
pseudo-forming rbsR 1 bp ins (homopol)
pseudo-forming rhlB 2 bp ins
pseudo-forming SSPA3202 1 bp ins (homopol)
pseudo-forming tesB 352 bp del
pseudo-forming wcaA 1 bp ins (homopol)
pseudo-forming yaaJ 1 bp del (homopol)
pseudo-forming yeaG 1 bp del
pseudo-forming yeeO 1 bp ins (homopol)
already pseudo SSPA4008a 1338 bp ins (IS10)
coding change pduP 6 bp VNTR
coding change rcnA 12 bp VNTR
coding change rmbA 9 bp del
coding change SSPA3558a 10 bp del
coding change ytfM 3 bp del
coding change* SSPA0733,4,5 5770 bp VNTR
intergenic - 1 bp ins (homopol)
intergenic - 1 bp ins (homopol)
intergenic - 3 bp ins (homopol)
intergenic - 1 bp ins
intergenic - 1 bp ins
intergenic - 1 bp ins
intergenic - 1 bp ins
intergenic - 1 bp ins
intergenic - 122 bp VNTR
RNA rtT RNA 175 bp VNTR
rRNA rrlC 1 bp del (homopol)
rRNA rrlD 1 bp ins (homopol)
rRNA rrsD 1 bp ins
sRNA csrB 1 bp ins (homopol)
tRNA proL 7 bp del
tRNA tRNA-Gly 220 bp VNTR
Del – deletion; ins – insertion; homopol – insertion or deletion in
homopolymeric sequence; IS10 – IS10 transposase insertion; VNTR –
variable number tandem repeat. Pseudo-forming – mutation results in
formation of a pseudogene in one strain; coding change – mutation results
in a change to the translated amino acid sequence but retains the reading
frame; * fusion of two genes, retaining the reading frame.
BMC Genomics 2009, 10:36 http://www.biomedcentral.com/1471-2164/10/36
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ATCC9150. Smaller VNTRs were identified within pduP
and rcnA, resulting in repeats of two and four amino acids
respectively in the encoded proteins. VNTRs are useful as
genetic markers for typing Salmonella enterica serovars, and
variability in the rcnA VNTR among Paratyphi A isolates
has been reported previously [24].
Single nucleotide polymorphisms (SNPs)
In addition to insertion/deletion events, 188 SNPs were
identified. These include 101 non-synonymous and 51
synonymous SNPs, giving a dN/dS ratio of 0.62, similar
to that observed between diverse Typhi strains [25].
While extreme care must be taken in interpreting dN/dS
ratios based on the comparison of two closely related
genomes [26], this ratio is consistent with some degree
of purifying selection in the Paratyphi A population.
Differences in pseudogene complements
The Paratyphi A AKU_12601 genome contains 204
pseudogenes, constituting 4.8% of annotated CDSs.
Although our comparative analysis revealed very few
sequence differences between the two Paratyphi A
genomes (188 SNPs, 39 insertion/deletion events),
these differences include 22 pseudogene-forming muta-
tions (see Table 2). The mutations include six nonsense
SNPs and 16 insertion/deletion events, and were verified
by inspecting the capillary sequencing traces and
Illumina reads data for Paratyphi A AKU_12601. This
suggests that pseudogene-forming mutations are con-
tinuing to accumulate in Paratyphi A, as has been
observed in Typhi [12, 25].
Comparison of pseudogenes in
Paratyphi A and Typhi genomes
In order to comprehensively investigate the mechanisms
of convergent gene loss in Paratyphi A and Typhi, we
assembled a comparative table of pseudogenes present
in each serovar (Additional file 1). This analysis includes
all previously annotated pseudogenes, some additional
Typhi pseudogenes suggested previously [13] and some
novel pseudogenes identified by manually inspecting
Typhi and Paratyphi A sequences for all genes annotated
as pseudogenes in any of the AKU_12601, ATCC9150,
CT18 or Ty2 genomes (see Methods).
Shared pseudogenes
The resulting table includes 66 pseudogenes common
to Typhi (strains CT18, Ty2) and Paratyphi A (strains
AKU_12601, ATCC9150) (Additional file 1). This is
almost double the figure reported previously [13],
although many of the additional pseudogenes are
remnants of transposase or bacteriophage genes. By
aligning the Typhi and Paratyphi A DNA sequences for
the shared pseudogenes, we identified shared and
independent inactivating mutations (Additional file 1).
Contrary to previous reports [13], we found common
inactivating mutations in many of the shared
pseudogenes.
The functions of most of the shared pseudogenes was
discussed by the authors of the ATCC9150 genome study
[13] and need not be repeated here. Of particular note,
however, 20 of the shared pseudogenes (54% of non-
phage/transposase shared pseudogenes) encode secreted
or surface-exposed proteins (Table 3), thus are likely to
have contributed to convergence upon similar patterns
of host interactions. Furthermore, inactivation of differ-
ent genes in the same pathway will often result in similar
loss of function, thus the true contribution of pseudo-
gene formation to phenotypic convergence between
Typhi and Paratyphi A is likely underestimated by
considering only shared pseudogenes. For example,
different members of the cbi cluster are inactivated in
Typhi and Paratyphi A, which may result in similar
inactivation of the cobalamin synthesis pathway [13].
Were pseudogenes shared by recombination?
Recombination has clearly been an important mechan-
ism of convergence between Paratyphi A and Typhi [15].
The accumulation of pseudogenes is a convergent
trait evident in these genomes, and shared patterns of
pseudogene formation is a likely mechanism for
phenotypic convergence. But did recombination con-
tribute to the sharing of pseudogenes?
More than 30% of the pseudogene complements of
Typhi and Paratyphi A were shared (Additional file 1),
consistent with the possibility that recombination of
23% of the genomes resulted in direct sharing of many
of their pseudogenes. We determined whether each
SSPA0733
rfbX
SSPA0734
rfbV
SSPA0735
rfbU
SPA0779 SPA0780 SPA0781 SPA0782 SPA0783 SPA0784 SPA0785
Figure 1
Tandem repeats in the O-antigen biosynthesis cluster
in Paratyphi A ATCC9150. Bottom row: gene
arrangement in Paratyphi A AKU_12601 and Typhi,
presumed to be the ancestral form. Top row: gene
arrangement in Paratyphi A ATCC9150, apparently resulting
from two tandem duplications. Labels give systematic
identifiers for the gene sequences in each genome, identical
coding sequences are shown in the same colours, identical
sequences are joined by lines.
BMC Genomics 2009, 10:36 http://www.biomedcentral.com/1471-2164/10/36
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pseudogene lay in regions that were predicted to have
undergone relatively recent recombination between
Paratyphi A and Typhi (sequence divergence < 0.3%
between serovars according to [15]) (see Additional file
1). Of all the pseudogenes present in both Paratyphi
A AKU_12601 and ATCC9150, 24.3% lie in recently
recombined regions; of the pseudogenes present in both
Typhi CT18 and Ty2, 25.0% lie in recombined regions.
According to [15], 25.6% of genes in CT18 lie in the
recently recombined regions.
These observations are consistent with two scenarios,
illustrated in Figure 2: (1) most pseudogenes were
inactivated prior to recombination, and recombination
was random with respect to the location of pseudogenes
(Figure 2b); or (2) most pseudogenes were inactivated
after recombination, and these pseudogene-forming
mutations were random with respect to recombined
regions (Figure 2c). If (1) were true, we would expect
that (i) genes that are pseudogenes in one serovar but
intact in the other (i.e. serovar-specific pseudogenes)
would not lie in recombined regions, and (ii) most
pseudogenes in recombined regions would have been
shared during recombination, i.e. they would be
pseudogenes in both Paratyphi A and Typhi and share
common inactivating mutations in both genomes (red
circles in Figure 2b). If (2) were true, we would expect
that (i) serovar-specific pseudogenes would be distrib-
uted randomly with respect to recombined and non-
recombined regions, and (ii) very few pseudogenes
would have been shared during recombination, i.e.
very few pseudogenes in recombined regions would
share inactivating mutations (red circles in Figure 2c).
The distribution of serovar-specific and shared pseudo-
genes in recombined and nonrecombined regions is
shown in Figure 2a and summarised in Table 4. Pearson
c2 tests for each serovar based on this data give non-
significant results (p - value > 0.2, Table 4), thus there is
no evidence of association between shared or serovar-
specific pseudogenes and regions of recombination,
consistent with scenario (2). More than 20% of
serovar-specific pseudogenes lie in recombined regions
of each genome (Figure 2a, black lines in inner ring),
consistent with scenario (2) whereby serovar-specific
pseudogenes are expected to be randomly distributed
in the genome of which 23% has been recombined
(Figure 2c, black lines in inner ring). These observations
are extremely unlikely under scenario (1), which would
predict recombination to result in shared but not
serovar-specific pseudogenes being present in recom-
bined regions (Figure 2b, inner ring).
We found only 18 pseudogenes in recombined regions
harboured the same inactivating mutations (red lines
and circles in inner rings, Figure 2a), less than 20% of
pseudogenes in the recombined regions of each genome
(Additional file 1). As illustrated in Figure 2, this is
consistent with scenario (2) but not scenario (1), which
would predict that most pseudogenes lying in
Table 2: Inactivating mutations unique to either AKU_12601 or ATCC9150
Gene Mutation Strain Gene product
aidB del AKU_12601 probable acyl Co-A dehydrogenase
asnB 1 bp del (homopol) ATCC9150 asparagine synthetase B
ccmH 88 bp del AKU_126 cytochrome c-type biogenesis protein H2
gltJ nonsense SNP AKU_12601 glutamate/aspartate transport system permease
nmpC IS10 ins AKU_12601 outer membrane porin
pduF 1 bp del (homopol) ATCC9150 propanediol diffusion facilitator
pduG 171 bp del AKU_12601 propanediol dehydratase reactivation protein
proQ 7 bp del ATCC9150 ProP effector
rbsC 1 bp ins (homopol) ATCC9150 high affinity ribose transport protein
rbsR 1 bp ins (homopol) ATCC9150 ribose operon repressor
rhlB 2 bp ins ATCC9150 putative ATP-dependent RNA helicase
SSPA1447 nonsense SNP AKU_12601 putative oxidoreductase
SSPA3202 1 bp ins (homopol) AKU_12601 putative lipoprotein
SSPA3581 nonsense SNP AKU_12601 conserved hypothetical protein
tesB 352 bp del ATCC9150 acyl-CoA thioesterase II
trpD nonsense SNP AKU_12601 anthranilate synthase component II
wcaA 1 bp ins (homopol) AKU_12601 putative glycosyl transferase
yaaJ 1 bp del ATCC9150 putative amino-acid transport protein
yeaG 1 bp del ATCC9150 conserved hypothetical protein
yeeO 1 bp ins (homopol) ATCC9150 putative inner membrane protein
yhaO nonsense SNP ATCC9150 putative transport system protein
yjhW nonsense SNP ATCC9150 putative membrane protein
Insertion, deletion or substitution events identified between Paratyphi A strains AKU_12601 and ATCC9150, causing gene inactivation in one strain.
Strain – Paratyphi A strain in which the inactivating mutation occurs; del – deletion; ins – insertion; homopol – variation in homopolymeric sequence.
BMC Genomics 2009, 10:36 http://www.biomedcentral.com/1471-2164/10/36
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recombined regions would be shared by virtue of
recombination and therefore carry the same inactivating
mutations (red circles in Figure 2).
The patterns of pseudogene distribution we observe
therefore suggest that the majority of pseudogenes
present in the extant genomes of Paratyphi A and Typhi
accumulated after the recombination of 23% of their
genomes. Whether this relationship is causal though,
remains to be proven. The acceleration of pseudogene
formation is most likely due to a combination of host-
adaptation and genetic drift associated with a population
bottleneck in the new human-restricted niche. However
whether the extensive recombination between Typhi
and Paratyphi A resulted in, or resulted from, human-
restriction of the two organisms, is unknown. It is
plausible that host-restriction occurred independently in
Typhi and Paratyphi A, providing both (a) an opportunity
for recombination soon after they became isolated
together in this shared niche, and (b) a trigger for
Table 3: Pseudogenes shared between Paratyphi A and Typhi
Class SSPA STY Gene Gene product Div.
i^ 0062a n/a - putative viral protein -
i^ 0255a n/a - putative uncharacterized protein -
i 1103 1362 - Pertussis toxin subunit S1 related protein 1.22%
i^ 1699a 0971 sopD2 *secreted effector protein SopD homolog 1.73%
i^ 2014 0610 silA *putative inner membrane proton/cation antiporter 1.08%
i^ 2014a 0609a cusS *putative copper-ion sensor protein 0.18%
i^ 3229 4202 - putative phosphosugar-binding protein 0.14%
i 3640 3800 cdh CDP-diacylglycerol pyrophosphatase 2.32%
i^ 3888 4728a - putative uncharacterized protein 1.35%
i 30 transposase/phage genes
and gene remnants, details
available in Additional file 1
ii 0097 0113 - *putative secreted protein 0.25%
ii 0431b 2631 - putative IS transposase 0.24%
ii 0754a 2275 sopA *secreted effector protein 0.23%
ii 3228 4203 - putative L-asparaginase 0.14%
ii 3365a 4037 sugR putative uncharacterized protein (SPI-3) 0.14%
iii 0192a 0218 fhuA *ferrichrome-iron receptor precursor 23.95%
iii 0317a 2775 - putative anaerobic dimethylsulfoxide reductase component 1.79%
iii 0329a 2762 sivH *putative invasin (CS54) 1.17%
iii 0331a 2758 ratB *putative lipoprotein (CS54) 1.67%
iii 0331b 2755 shdA *putative uncharacterized protein (CS54) 2.11%
iii 0621a 2422 mglA *galactoside transport ATP-binding protein 1.09%
iii 0720a 2311 wcaK *putative extracellular polysaccharide biosynthesis protein 1.82%
iii 0756a 2268 yeeC penicillin-binding protein 2.19%
iii 0850a 2166 fliB lysine-N-methylase 3.11%
iii 0943a 1995 - transposase 4.77%
iii 1014a 1913 hyaA hydrogenase-1 small subunit 0.33%
iii 1220a 1508 - *putative transport protein 1.31%
iii 1367a 1739 - putative ribokinase (SPI-2) 1.42%
iii 1531a 1244 fhuE *FhuE receptor precursor 0.96%
iii 1642a 1104 - *putative secreted protein 1.54%
iii 1820a 0833 slrP *secreted effector protein 1.95%
iii 2045a 0569 ybbW *putative allantoin transporter 1.19%
iii 2301a 0333 safE *probable lipoprotein (SPI-6 fimbrial cluster) 1.52%
iii 3388a 4007 - putative cytoplasmic protein 1.12%
iii 3636a 3805 - *putative permease of the Na+:galactoside symporter family 2.42%
iii 3828b 4503 dmsA anaerobic dimethyl sulfoxide reductase chain A 0.22%
iii 3998a 4839 sefD *putative fimbrial protein (SPI-10) 0.18%
iii, iv1 1197a 1486 narW respiratory nitrate reductase 2 delta chain 1.74%
iii, iv2 2900a 3421 yhaO *putative transport system protein 0.58%
iv3 0708 2328 wcaA putative uncharacterized protein 1.35%
(i) Ancestral pseudogenes (shared by virtue of inheritance in inactived gene from a common ancestor); ^ intact in Typhimurium, note that 30
ancestral pseudogenes encoding phage or transposase genes are excluded here but listed in Additional file 1. (ii) Recombined pseudogenes (shared by
recombination). (iii) Recent conserved pseudogenes (independent inactivating mutations in each serovar). (iv) Recent strain-specific pseudogenes
(pseudogenes in some but not all strains belonging to their respective serovar); 1pseudogene in Paratyphi A (both strains) and Typhi Ty2,
2pseudogene in Typhi (both strains) and Paratyphi A ATCC9150, 3pseudogene in Paratyphi A ATCC9150 and Typhi CT18. SSPA and STY -systematic
identifiers in Paratyphi A AKU_12601 and Typhi CT18 respectively; n/a – not annotated. For genes lying in Salmonella pathogenicity islands (SPIs) the
island is indicated in brackets after the gene product. Div. – nucleotide divergence reported in [15].
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accelerated pseudogene formation. Alternatively, a
chance recombination event may have led to host-
restriction of both organisms. It has been noted that
recombination between Paratyphi A and Typhi involved
sharing of intact serovar-specific or rare genes, resulting in
many more shared rare genes than would be expected
otherwise [15] and presumably promoting the sharing of
novel functions. It is plausible therefore that recombina-
tion between Paratyphi A and Typhi led to a combination
of gene acquisition and loss-of-function resulting in
restriction to the human host, bestowing upon these
serovars a unique and novel genetic profile that con-
tributed to host restriction and the ability to cause
systemic infection. Such an event would likely set
Paratyphi A and Typhi on a similar trajectory of host
adaptation and associated population bottlenecks, which
might account for their similar profiles of rapid accumu-
lation of pseudogenes through adaptive selection and
genetic drift.
Tracing pseudogene formation in the evolutionary
histories of Paratyphi A and Typhi
The recombination described between Paratyphi A and
Typhi provides a rare marker of relative time in the
evolutionary histories of these organisms. The recombi-
nation was discovered by analysing the distribution of
nucleotide divergence levels between different regions of
the two genomes, which clearly identified a distinct
sub-population of low divergence corresponding to the
recombined regions (mean 0.18% compared to genome
average of 1.2%) [15]. Although not providing a precise
measure of age, this suggests that the recombination
event happened approximately 15% (0.18/1.2 = 0.15) as
long ago as the initial divergence of Paratyphi A, Typhi
and other S. enterica serovars. This implies that recombi-
nation occurred well before the most recent common
ancestors of each serovar (see Figure 3), and thus prior to
the last population bottlenecks in the Paratyphi A and
Typhi populations.
We divided the pseudogenes into distinct categories with
different relative ages (Additional file 1): (i) ancestral
pseudogenes (shared pseudogenes inactivated prior to
the divergence of Paratyphi A and Typhi), (ii) recom-
bined pseudogenes (shared pseudogenes in recombined
regions, with shared inactivating mutations assumed to
have arisen after initial divergence), (iii) recent con-
served pseudogenes (including serovar-specific pseudo-
genes, and shared pseudogenes containing different
inactivating mutations in Paratyphi A and Typhi; the
majority of these are expected to have become pseudo-
genes after recombination) and (iv) recent strain-specific
pseudogenes (pseudogenes in some but not all strains
belonging to their respective serovar). Table 3 sum-
marises the shared pseudogenes in each category
(excluding ancestral transposase/phage gene remants)
and Figure 3 shows their approximate timing overlaid on
a phylogenetic tree of S. enterica serovars. Note that some
serovar-specific pseudogenes (group iii) will likely be
Paratyphi A Typhi
Most recent
common 
ancestor
Serovar 1
Serovar 2
Serovar 1
(donor)
Serovar 2
(recipient)
a
b
c
Pseudogenes
    ancestral
 |   independently acquired
        (including 22 common to both)
•   shared by recombination
        (not ancestral)
Inner ring: recombined regions
Outer ring: nonrecombined regions
Serovar 1
Serovar 2
Serovar 1
(donor)
Serovar 2
(recipient)
Serovar 1
Serovar 2
recombination
pseudogene
accumulation
recombination
pseudogene
accumulation
Figure 2
Scenarios of recombination and pseudogene
formation in Paratyphi A and Typhi. (a) True
distribution of pseudogenes in the Paratyphi A AKU_12601
and Typhi CT18 genomes (gene order based on gene co-
ordinates in Typhi CT18). (b-c) Distribution of pseudogenes
resulting from data simulated under two scenarios, under
both of which 40 pseudogenes are inherited from the most
recent common ancestor of Paratyphi A and Typhi, and
extensive accumulation of pseudogenes occurs before or
after recombination of 25% of genes. For ease of simulation,
the recombination shown is uni-directional, but bi-
directional exchange would result in similar patterns. (b)
Scenario 1: 150 additional pseudogenes accumulate in each
serovar, followed by recombination. (c) Scenario 2: only 20
additional pseudogenes arise before recombination, after
which a further 150 pseudogenes accumulate in each
serovar.
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shown to be strain-specific (group iv) as more strains are
sequenced (see below).
Ancestral pseudogenes
The inactivating mutations in group (i) pseudogenes are
assumed to have been inherited by Paratyphi A and Typhi
from a common ancestor (Figure 3). Alternatively some
may have been exchanged between Paratyphi A and Typhi
soon after their divergence from other S. enterica. Either
way, these pseudogenes were among the earliest to arise in
the evolutionary history of Paratyphi A and Typhi, thus
their inactivation has been well tolerated in these serovars
(most have also accumulated secondary mutations). This is
unsurprising for the majority of ancestral pseudogenes
which are insertion sequence (IS) transposase and phage
genes/fragments. However the inactivation of seven genes
known to be functional in Typhimurium and other
Salmonella, in particular those that are secreted or surface
exposed (Table 3), is likely to have had significant
functional impact including potential modulations of
host interactions. It is also possible that the loss of these
genes had little effect on the pathogenic potential of
Paratyphi A and Typhi and that they had classic S. enterica
host-generalist lifestyles until much later on. However the
best described of these seven co-inherited pseudogenes is
the secreted effector protein sopD2, which in Typhimurium
is involved in host interactions and virulence [27] and
therefore constitutes a plausible candidate for an early
modulator of host interactions in Paratyphi A and Typhi.
Pseudogenes shared by recombination
Group (ii) contains five recombined pseudogenes (Table 3),
which display 0.14–0.25% nucleotide divergence between
the two serovars compared to a genome average of 1.2%and
thus were likely exchanged long after the initial divergence
of Paratyphi A and Typhi (Figure 3). One of these encodes
an IS transposase, leaving four candidates for convergence
via shared gene inactivation directly attributable to recom-
bination. These include the secreted effector protein sopA,
which mimics mammalian ubiquitin ligase and is recog-
nized and degraded by the human ubiquitination pathway
[28]. It is necessary for virulence in both murine systemic
infections and bovine gastrointestinal infections by Typhi-
murium [29, 30], thus is clearly important for interactions
between Salmonella and mammalian hosts. The loss of this
gene in Paratyphi A and Typhi may therefore have been an
important factor in the restriction or adaptation of these
serovars to the human systemic niche. SopA is also a
pseudogene in the sequenced Paratyphi B strain SPB7
[EMBL:CP000886], although this is difficult to interpret as it
is unclear whether this strain is of the systemic or enteric
pathotype (negative for tartrate fermentation, but also sopE-
negative using PCR described in [31]). The other genes are
putative uncharacterised SPI-3 protein sugR, and two genes
not annotated previously in the ATCC9150 genome –
putative secreted protein SSPA0097 (interrupted by IS200
insertion) and putative L-asparaginase protein SSPA3228
(truncated at both ends by deletions).
Table 4: Distribution of serovar-specific and shared pseudogenes in recombined regions
Distribution Recombined Nonrecombined c2 test, specific vs. shared
Typhi-specific 114 39 0.33 (p-value = 0.57)
Paratyphi A-specific 92 24 1.63 (p-value = 0.20)
Shared 46 20
Pearson c2 tests were performed separately for each serovar based on the two-way contingency table obtained from the respective serovar-specific
row and shared row.
Typhimurium SL1344
Typhimurium LT2
Paratyphi B
Paratyphi A AKU_12601
Paratyphi A ATCC9150
Typhi TY2
Typhi CT18
(i) ancestral 
pseudogenes
slow accumulation of 
pseudogenes in all serovars
0.0010
(ii) recombined
pseudogenes
rapid accumulation
of pseudogenes in 
Paratyphi A and Typhi
(iii) conserved
(iv) strain-specific
pseudogenes
recombination
Figure 3
Pseudogene formation in the evolutionary histories
of Paratyphi A and Typhi. Phylogenetic tree based on
multiple alignments of all nonrecombined genes as defined in
[15], rooted using S. bongori and E. coli as outgroups. Scale
bar is nucleotide divergence. The timing of the
recombination between Paratyphi A and Typhi is an
approximation inferred from published divergence data [15].
Group (i) pseudogenes were inactivated prior to the
divergence of Paratyphi A and Typhi, some are also
inactivated in Typhimurium and Paratyphi B; following their
divergence Paratyphi A and Typhi likely accumulated few
additional pseudogenes; during the recombination of 23% of
their genomes (direction of transfer unknown) 18
pseudogene sequences were shared between Paratyphi A
and Typhi, including five non-ancestral pseudogenes (group
ii); many pseudogenes were formed during a period of
accelerated pseudogene accumulation in both serovars,
including most group (iii) pseudogenes; pseudogenes
continue to accumulate in individual sub-lineages after the
most recent common ancestor of each serovar (group iv).
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Recent pseudogenes: convergence after recombination
In addition to > 100 pseudogenes specific to each serovar,
group (iii) includes 22 shared pseudogenes containing
different inactivating mutations in Paratyphi A and Typhi
(Table 3). While it is possible that some of those lying
outside recombined regions may have been present prior
to recombination, we propose that most of these muta-
tions arose in the period of rapid pseudogene accumula-
tion after recombination. These pseudogenes are examples
of convergent gene loss through independent mutation,
and are therefore good candidates for involvement in
adaptation to the human host. They include only one
transposase gene, the remainder being genes of known or
putative function, many of which have been implicated in
host interactions in serovar Typhimurium (e.g. fhuA, fhuE,
shdA, ratB, sivH) [13, 32]. Two of the independently
acquired pseudogenes, both members of fimbrial clusters
lying in Salmonella pathogenicity islands (safE in SPI-6, sefD
in SPI-10), were not identified in previous pseudogene
comparisons [13].
It is not possible to distinguish whether there has been
adaptive selection against the activity of these genes in
Paratyphi A and Typhi, or simply shared tolerance for
their inactivation. For example, it has been noted [13]
that three of these genes (shdA, ratB and sivH, part of the
25 kbp pathogenicity island CS54 [32]) are involved in
intestinal colonization and persistence, which does not
occur in typhoid or paratyphoid infection. However we
cannot distinguish whether the independent inactivation
of these genes in each serovar is due to selection against
colonization of the intestine (which may stimulate
host immune responses), or genetic drift since intestinal
colonization is not required to sustain a systemic
infection.
Ongoing accumulation of strain-specific pseudogenes
A recent comparative analysis of whole-genome varia-
tion in 19 Typhi strains inferred that their last common
ancestor harboured only 180 pseudogenes, while indi-
vidual isolates had each accumulated at least 10–28
additional pseudogenes since their divergence from
that ancestor [25]. The number was predicted to be an
underestimate, as it did not take into account pseudo-
gene formation via insertion/deletion of one or two
nucleotides which would introduce frameshifts. In our
comparison of the AKU_12601 and ATCC9150 genomes
we found 22 mutations resulting in strain-specific
pseudogene formation (10–12 per strain, Table 2), and
we predict that future comparative analyses of additional
strains will uncover further examples of recently acquired
strain-specific pseudogenes. These strain-specific pseu-
dogenes must have arisen since the most recent common
ancestors of the respective Paratyphi A and Typhi
populations and are therefore more recent than those
that are conserved within the serovars (see Figure 3). It is
interesting to note that three genes were identified with
strain-specific mutations in one serovar and independent
mutations in the other serovar (see Additional file 1).
This may provide the opportunity for ongoing conver-
gence between sub-lineages of the Typhi and Paratyphi
A populations as each serovar continues to evolve and
adapt.
Conclusion
The Paratyphi A AKU_12601 genome sequence pre-
sented here allowed the first whole-genome comparison
between Paratyphi A strains. By comparing the annota-
tion of pseudogenes in these Paratyphi A genomes and
the two finished Typhi genomes CT18 and Ty2, we were
able to identify novel examples of pseudogenes that are
shared between these human-adapted serovars. Paraty-
phi A and Typhi have each undergone a parallel, rapid
accumulation of pseudogenes after extensive recombina-
tion of their genomes.
Although Paratyphi A and Typhi share 27 pseudogenes
over and above those inherited in inactive form from a
common ancestor, only five were shared via recombina-
tion while 22 are the result of more recent convergence
through independent adaptive mutation. Therefore
recombination and pseudogene formation have played
largely independent roles in the genetic convergence of
Paratyphi A and Typhi.
The recombination between Paratyphi A and Typhi
enabled us to identify different groups of pseudogenes
that have arisen in these genomes at different points in
their evolutionary histories. This implicates loss-of-
function of a few genes in early restriction to the
human host (ancestral pseudogenes including sopD2)
and some in subsequent convergent adaptation to the
new niche (conserved and in particular shared conserved
pseudogenes including shdA, ratB, sivH). Pseudogenes
shared by recombination (e.g. sopA) may have contrib-
uted to host-restriction or host-adaptation.
While the analysis presented here considers only Para-
typhi A and Typhi, there are other examples of human-
adapted S. enterica serovars, including Sendai, Paratyphi
C and the systemic pathovar of Paratyphi B. It can be
expected that as genome sequences for these become
available, comparative analysis may yield further
insights into their mechanisms of host adaptation.
However the occurrence of relatively recent recombina-
tion between Paratyphi A and Typhi has afforded a
unique insight into the order of events and mechanisms
involved in their convergent evolution, a scenario which
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has likely been played out in many other host-adapted
bacteria.
Methods
Sequencing of AKU_12601
Paratyphi A strain AKU_12601 was isolated from a
Pakistani paratyphoid patient in Karachi, Pakistan in
2002. The whole-genome shotgun consisted of 83,857
paired-end reads from libraries of 2 to 2.8 kb in pUC19,
5 to 6 kb in pMAQ1, and 6 to 9 kb in pMAQ1, giving
9.8-fold coverage. A scaffold was produced using 1,180
paired-end reads from a 20- to 30-kb library in
pBACe3.6. The whole genome sequence was finished to
standard criteria [33], using 9,879 directed sequencing
reads. The sequence was annotated, and the annotation
was manually curated using Artemis software [34] as
previously described [33]. The sequence includes both
the chromosome, presented here, and the 212,711 bp
IncHI1 multidrug resistance plasmid pAKU_1 which has
been described in detail elsewhere [22]. AKU_12601 was
also resequenced using the Illumina Genome Analyzer
(Illumina), with 3,191,127 single-end 35 bp reads
providing 21.9-fold coverage of the chromosome.
Sequence comparisons
Maq [35] was used to map Illumina/Solexa 35 bp reads
to the finished AKU_12601 sequence and identify
potential errors (reported as SNPs by Maq using default
parameters). Capillary traces were manually inspected
for the five loci at which SNPs were reported by Maq
with consensus base quality > 20 and read depth > 5.
Pairwise whole-genome sequence comparisons were
generated with blastn and visualized using ACT [36].
Insertions, deletions and nucleotide substitutions
between the collinear Paratyphi A AKU_12601 and
ATCC9150 genomes were identified using diffseq
(EMBOSS [37]).
Comparison and annotation of pseudogenes
In order to compare annotated genomes of Paratyphi A
AKU_12601 [EMBL:FM200053] and ATCC9150 [EMBL:
CP000026], Typhi CT18 [EMBL:AL513382] and Ty2
[EMBL:AE014613] with Typhimurium LT2 [EMBL:
AE006468], pairwise whole-genome sequence compar-
isons were generated with blastn and visualized using
ACT [36]. Every gene annotated as a pseudogene in any
Typhi or Paratyphi A genome was manually inspected in
all five genomes, and its pseudogene status in each
genome reassessed. All pseudogenes identified in this
way are present in the AKU_12601 genome annotation,
although many such genes are not annotated in all of
ATCC9150, CT18 and Ty2. For coding sequences found
to be a pseudogene in more than one serovar, multiple
alignments were used to determine whether the same or
independent inactivating mutation(s) were present in
the different serovars.
Data simulation
An initial set of 40 genes were selected at random to
represent ancestral pseudogenes. Additional sets of 20
and 150 genes were selected at random for each of two
serovars, to represent pseudogenes that accumulated
after initial divergence of the serovars (sampling with
replacement). The same random sets of pseudogenes
were used to simulate both scenarios, with only the
timing varying (set of 150 pseudogenes arising before or
after recombination). To simulate uni-directional recom-
bination events depicted in Figure 2, serovar 2 pseudo-
genes lying in recombined regions were replaced with
serovar 1 pseudogenes lying in recombined regions. All
genes were selected at random from 4600 annotated in
Typhi CT18, and their status as recombined or non-
recombined was taken directly from the table of Typhi
genes provided in [15].
Phylogenetic analysis
Nucleotide sequences for genes that have not undergone
recent recombination between Typhi and Paratyphi A
(according to the table provided in [15]) were extracted
from the CT18 genome sequence using Artemis. Homo-
logous sequences in other genomes were identified using
blastn, top scoring gapped sequence alignments for each
genome were assembled into a single multiple alignment
for each gene using Mview [38], which were then
concatenated. The analysis included Typhimurium
(strains LT2, SL1344) and S. enterica serovar Paratyphi
B SPB7 [EMBL:CP000886], S. bongori and E. coli K12
[EMBL:U00096] were included as outgroups to root the
tree. The S. bongori and Typhimurium SL1344 sequences
are available from the Wellcome Trust Sanger Insitute
[39]. MrBayes [40] was used to fit a phylogenetic model
to the concatenated multiple alignment of all (non-
recombined) genes (GRT+Γ model, 200,000 iterations),
Figure 3 shows the consensus tree.
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Typhi CT18, Ty2. Details of all pseudogenes present in finished genomes
of Paratyphi A or Typhi, including gene identifiers in all four genomes,
nucleotide divergence between Paratyphi A and Typhi, and classification
into different classes: pseudogenes in both Paratyphi A and Typhi
(ancestral, shared by recombination, independent mutations),
pseudogenes in either Paratyphi A or Typhi, and genome-specific
pseudogenes.
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